Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 6 days agoALK is a gene that is “switched off” in the womb but can turn back on for some people and cause ...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 2 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 1 day agodifferent mutation. The KRAS gene is typically the first to mutate in the cascade of genetic changes...
Catching cancer early lowers risk of mortality, but screening is the first step
Stacker via AOL· 5 hours ago"For certain cancers, disparities in stage of diagnosis despite comparable screening rates may be...
‘Whew. He didn’t say avoid Diet Coke’: Cancer doctor shares the 5 things he ‘would never do’
The Daily Dot· 14 hours agoA popular oncology dietician just took her followers with her to the grocery store to show them...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
The Pendulum· 4 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous NSCLC, regardless of PD-L1 expression ...
Study: Access to targeted lung cancer drug is cost-prohibitive globally
Medical Xpress· 6 days agoThe findings show that the drug exceeded official cost-effectiveness thresholds for all four analyzed countries: the United States, Brazil, Singapore and Spain. The study could help guide...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 4 days agoLayman also didn’t take part in the trial, but is an investigator in a different Enhertu study....